Tempus AI (TEM)
64.62
-0.04 (0.06%)
Upcoming Events
Latest Headlines
Tempus AI Inc (TEM) PT Raised to $70 at Baird
September 3, 2026 7:06 AM - StreetInsider
Cantor Fitzgerald Starts Tempus AI Inc (TEM) at Overweight
September 2, 2026 6:07 AM - StreetInsider
Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
September 1, 2026 3:54 AM - StreetInsider
Piper Sandler Upgrades Tempus AI Inc (TEM) to Overweight, 'On A Train Back To Upside, We're Not Jumping the Gun'
September 1, 2026 3:45 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Aug 25 Filed by: LEFKOFSKY ERIC P
August 27, 2026 8:29 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 25 Filed by: LEFKOFSKY ERIC P
August 27, 2026 8:27 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
August 25, 2026 4:58 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 21 Filed by: Fukushima Ryan
August 25, 2026 4:15 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 21 Filed by: Schoenherr Thomas Edward
August 25, 2026 4:15 PM - SEC Filing
Tempus AI gets FDA clearance for ECG-based AI pulmonary hypertension tool
August 24, 2026 8:32 AM - StreetInsider
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
August 24, 2026 8:30 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 21, 2026 4:34 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
August 21, 2026 4:33 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: LEFKOFSKY ERIC P
August 20, 2026 9:01 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Fukushima Ryan
August 20, 2026 9:01 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Schoenherr Thomas Edward
August 20, 2026 9:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Polovin Andrew
August 20, 2026 9:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Bartolucci Ryan M
August 20, 2026 9:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 18 Filed by: Rogers James William
August 20, 2026 9:00 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
August 19, 2026 5:04 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Polovin Andrew
August 19, 2026 5:02 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 19, 2026 5:01 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Bartolucci Ryan M
August 19, 2026 5:00 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Rogers James William
August 19, 2026 4:58 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
August 19, 2026 4:56 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Rogers James William
August 19, 2026 4:39 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Polovin Andrew
August 19, 2026 4:32 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Schoenherr Thomas Edward
August 19, 2026 4:32 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 14 Filed by: West Nadja
August 18, 2026 4:15 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: West Nadja
August 14, 2026 4:44 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 12 Filed by: Fukushima Ryan
August 14, 2026 4:34 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 07 Filed by: Fukushima Ryan
August 11, 2026 5:30 PM - SEC Filing
AI Found an Influenza Target That Survives Viral Mutation
August 10, 2026 9:10 AM - StreetInsider
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 7, 2026 4:37 PM - SEC Filing
CellCarta Adds Tempus to CDx Commercialization Lab Network
August 6, 2026 9:15 AM - PR NewsWire
Form 4 Tempus AI, Inc. For: Aug 03 Filed by: Epstein David R
August 5, 2026 4:31 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Aug 03 Filed by: Fukushima Ryan
August 5, 2026 4:30 PM - SEC Filing
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
August 4, 2026 8:30 AM - BizWire
Tempus AI Inc (TEM) PT Lowered to $56 at Piper Sandler
August 4, 2026 6:55 AM - StreetInsider
Tempus AI Inc (TEM) PT Lowered to $56 at H.C. Wainwright
August 4, 2026 6:50 AM - StreetInsider
Form 144 Tempus AI, Inc. Filed by: Epstein David R
August 3, 2026 4:49 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
August 3, 2026 4:18 PM - SEC Filing
Tempus AI Inc (TEM) PT Lowered to $70 at BTIG
August 3, 2026 1:49 PM - StreetInsider
Tempus AI Inc (TEM) PT Lowered to $50 at Stifel Amid Hereditary Weakness
August 3, 2026 8:02 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Jul 29 Filed by: Polovin Andrew
July 31, 2026 5:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Jul 29 Filed by: Rogers James William
July 31, 2026 4:59 PM - SEC Filing
Tempus AI Inc (TEM) PT Lowered to $59 at Baird
July 31, 2026 7:21 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Jul 28 Filed by: LEFKOFSKY ERIC P
July 30, 2026 9:43 PM - SEC Filing
Tempus AI, Inc (TEM) Tops Q2 EPS by 4c ; Offers Guidance
July 30, 2026 4:28 PM - StreetInsider
Form 10-Q Tempus AI, Inc. For: Jun 30
July 30, 2026 4:04 PM - SEC Filing
Form 8-K Tempus AI, Inc. For: Jul 30
July 30, 2026 4:01 PM - SEC Filing
Tempus Reports Second Quarter 2026 Results
July 30, 2026 4:01 PM - BizWire
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
July 28, 2026 4:40 PM - SEC Filing
TD Cowen reports short interest changes in life science stocks
July 27, 2026 12:15 PM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Tempus AI Inc (TEM)
July 24, 2026 7:26 AM - StreetInsider
Tempus AI launches OneOme pharmacogenomics testing nationally
July 22, 2026 8:31 AM - StreetInsider
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
July 22, 2026 8:30 AM - BizWire
Form 8-K Tempus AI, Inc. For: Jul 20
July 20, 2026 5:15 PM - SEC Filing
Jefferies Reiterates Underperform Rating on Tempus AI Inc (TEM)
July 20, 2026 4:54 PM - StreetInsider
Canaccord Reiterates Buy Rating on Tempus AI Inc (TEM)
July 20, 2026 1:30 PM - StreetInsider
Needham on Tempus AI Inc (TEM): 'Buyers of any weakness related to the transaction'
July 20, 2026 12:51 PM - StreetInsider
PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus
July 20, 2026 11:55 AM - StreetInsider
Needham Downgrades Personalis (PSNL) to Hold
July 20, 2026 11:34 AM - StreetInsider
Form 425 Tempus AI, Inc. Filed by: Tempus AI, Inc.
July 20, 2026 9:05 AM - SEC Filing
Form 8-K Tempus AI, Inc. For: Jul 20
July 20, 2026 9:04 AM - SEC Filing
Tempus AI to acquire Personalis in $1.5B stock deal
July 20, 2026 8:30 AM - StreetInsider
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
July 20, 2026 8:30 AM - BizWire
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
July 16, 2026 8:30 AM - BizWire
Tempus AI Inc (TEM) PT Raised to $65 at Guggenheim
July 16, 2026 6:38 AM - StreetInsider
Tempus AI Inc (TEM) PT Raised to $67 at Baird
July 13, 2026 7:18 AM - StreetInsider
Form 4 Tempus AI, Inc. For: Jul 08 Filed by: Fukushima Ryan
July 10, 2026 4:15 PM - SEC Filing
Tempus to Report Second Quarter 2026 Financial Results on July 30
July 9, 2026 9:00 AM - BizWire
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
July 8, 2026 5:00 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Jul 06 Filed by: Fukushima Ryan
July 8, 2026 4:15 PM - SEC Filing
Freedom Capital Starts Tempus AI Inc (TEM) at Hold
July 8, 2026 2:07 PM - StreetInsider
Form 144 Tempus AI, Inc. Filed by: Fukushima Ryan
July 6, 2026 4:45 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Jun 29 Filed by: LEFKOFSKY ERIC P
July 1, 2026 4:15 PM - SEC Filing
Freedom Capital Starts Tempus AI Inc (TEM) at Hold
June 30, 2026 4:22 PM - StreetInsider
Form 4 Tempus AI, Inc. For: Jun 25 Filed by: Rogers James William
June 29, 2026 8:40 PM - SEC Filing
Form 4 Tempus AI, Inc. For: Jun 25 Filed by: Doudna Jennifer A
June 29, 2026 8:40 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: LEFKOFSKY ERIC P
June 29, 2026 5:52 PM - SEC Filing
Form 144 Tempus AI, Inc. Filed by: Rogers James William
June 25, 2026 4:26 PM - SEC Filing
Tempus AI partners with Angiosarcoma Awareness on rare cancer data
June 25, 2026 8:31 AM - StreetInsider
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers
June 25, 2026 8:30 AM - BizWire
Tempus publishes validation study for FDA-cleared ECG AI model
June 11, 2026 8:30 AM - StreetInsider
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
June 11, 2026 8:30 AM - BizWire
TD Cowen notes short interest shifts in life science tools stocks
June 10, 2026 10:50 AM - StreetInsider
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
June 9, 2026 6:00 AM - BizWire
Full Article List
